10-Q Filing

XILIO THERAPEUTICS, INC. CIK: 1840233 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0001558370-23-018587`
Period End Date	20230930
Filing Date	20231109
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	xlo-20230930x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 52 Cash Flow Statement 56 Stockholders Equity 34

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$139.14M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$59.77M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$120.39M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.71M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.11M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$64.48M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$124.50M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.58M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.56M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.47M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$7.25M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.54M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.37M	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$5.25M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.53M	shares	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$5.58M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.43M	shares	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$267.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$169.00K	USD	Point-in-time
Total assets	`Assets`	$77.84M	USD	Point-in-time
Total assets	`Assets`	$139.16M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.12M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.49M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$9.40M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$10.33M	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$918.00K	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$1.01M	USD	Point-in-time
Note payable, current portion	`NotesPayableCurrent`	$6.67M	USD	Point-in-time
Note payable, current portion	`NotesPayableCurrent`	$4.96M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$68.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$82.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$21.12M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$16.93M	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	$3.17M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$8.41M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$9.19M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$45.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$25.34M	USD	Point-in-time
Total liabilities	`Liabilities`	$33.52M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 5,000,000 shares authorized, no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 5,000,000 shares authorized, no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized at September 30, 2023 and December 31, 2022; 27,542,000 shares issued and 27,528,926 shares outstanding at September 30, 2023; 27,471,607 shares issued and 27,425,447 shares outstanding at December 31, 2022	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized at September 30, 2023 and December 31, 2022; 27,542,000 shares issued and 27,528,926 shares outstanding at September 30, 2023; 27,471,607 shares issued and 27,425,447 shares outstanding at December 31, 2022	`CommonStockValue`	$3.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$354.75M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$360.35M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-249.11M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-307.86M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$144.22M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$166.12M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$52.50M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$84.79M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$105.65M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$185.43M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$67.38M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$126.30M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$139.16M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$77.84M	USD	Point-in-time

Income Statement 52 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$40.40M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$13.04M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$44.20M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$11.05M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$6.31M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$21.78M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$20.60M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$7.17M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$65.98M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$17.36M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$61.00M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$20.21M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-17.36M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-20.21M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-61.00M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-65.98M	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$613.00K	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$226.00K	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$2.25M	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$416.00K	USD	1 Quarter
Total other income, net	`NonoperatingIncomeExpense`	$2.25M	USD	3 Qtrs
Total other income, net	`NonoperatingIncomeExpense`	$226.00K	USD	3 Qtrs
Total other income, net	`NonoperatingIncomeExpense`	$613.00K	USD	1 Quarter
Total other income, net	`NonoperatingIncomeExpense`	$416.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-65.76M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-16.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.65M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-24.61M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.35M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-19.36M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-58.75M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-19.79M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-58.75M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-19.79M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-16.75M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-65.76M	USD	3 Qtrs
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.61	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-2.40	USD	3 Qtrs
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-2.14	USD	3 Qtrs
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.72	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.61	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.72	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-2.40	USD	3 Qtrs
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-2.14	USD	3 Qtrs
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.40M	shares	1 Quarter
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.52M	shares	1 Quarter
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.48M	shares	3 Qtrs
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.38M	shares	3 Qtrs
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	27.40M	shares	1 Quarter
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	27.48M	shares	3 Qtrs
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	27.52M	shares	1 Quarter
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	27.38M	shares	3 Qtrs

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-65.76M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-58.75M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.45M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.36M	USD	3 Qtrs
Non-cash interest expense	`NoncashInterestExpense`	$141.00K	USD	3 Qtrs
Non-cash interest expense	`NoncashInterestExpense`	$164.00K	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$6.61M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$5.45M	USD	3 Qtrs
Loss on disposal of property and equipment	`GainLossOnDispositionOfAssets`	$-3.00K	USD	3 Qtrs
Loss on disposal of property and equipment	`GainLossOnDispositionOfAssets`	$-1.00K	USD	3 Qtrs
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$597.00K	USD	3 Qtrs
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.28M	USD	3 Qtrs
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-288.00K	USD	3 Qtrs
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-338.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.62M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-972.00K	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-928.00K	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$116.00K	USD	3 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-591.00K	USD	3 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-679.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-55.19M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-57.50M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$486.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.36M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-486.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.36M	USD	3 Qtrs
Repayments of debt principal	`RepaymentsOfDebt`	$5.00M	USD	3 Qtrs
Payments of finance lease	`FinanceLeasePrincipalPayments`	$64.00K	USD	3 Qtrs
Payments of finance lease	`FinanceLeasePrincipalPayments`	$64.00K	USD	3 Qtrs
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromStockPlans`	$140.00K	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$16.00K	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$8.00K	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-4.92M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-48.00K	USD	3 Qtrs
Decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-60.59M	USD	3 Qtrs
Decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-58.91M	USD	3 Qtrs
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$140.70M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$61.35M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$199.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$199.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$140.70M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$61.35M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$380.00K	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$474.00K	USD	3 Qtrs
Capital expenditures included in accounts payable or accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$371.00K	USD	3 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$139.14M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$59.77M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$120.39M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$1.58M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$1.56M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$199.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$140.70M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$61.35M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.95M	USD	Point-in-time

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$144.22M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$166.12M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$52.50M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$84.79M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$105.65M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$185.43M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$67.38M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$126.30M	USD	Point-in-time
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$140.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$16.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$8.00K	USD	1 Quarter
Exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	2,757.00	shares	3 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.80M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.86M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.87M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.79M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.71M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.03M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-65.76M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-22.65M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-24.61M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-16.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-19.36M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.35M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-58.75M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-19.79M	USD	1 Quarter
Ending balance	`StockholdersEquity`	$67.38M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$144.22M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$166.12M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$52.50M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$84.79M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$105.65M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$185.43M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$126.30M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.